Long-term outcome after treatment with 5% topical imiquimod cream in patients with basal cell carcinoma of the eyelids

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 249, Issue 1, 2011, Pages 121-125

  Prokosch, Verena ^a   Thanos, Solon ^a   Spaniol, Kristina ^a   Stupp, Tobias ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Basal cell carcinoma; Eyelid; Imiquimod; Long term therapy outcome

Indexed keywords

IMIQUIMOD;

ADULT; AGED; APPLICATION SITE BURNING; APPLICATION SITE CRUSTING; APPLICATION SITE PRURITUS; APPLICATION SITE REACTION; APPLICATION SITE SCABBING; ARTICLE; BASAL CELL CARCINOMA; CLINICAL ARTICLE; CONJUNCTIVA DISEASE; CORNEA DISEASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EYELID CARCINOMA; FOLLOW UP; HUMAN; MALE; OFF LABEL DRUG USE; PRIORITY JOURNAL; PROGNOSIS; SIDE EFFECT; TREATMENT REFUSAL; VISUAL ACUITY;

ADMINISTRATION, TOPICAL; ADULT; AGED; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; EYELID NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 79951724288     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-010-1526-3     Document Type: Article

References (15)

1. CS Wong RC Strange JT Lear 2003 Basal cell carcinoma BMJ 327 794 798 1:STN:280:DC%2BD3svmtlWiuw%3D%3D 10.1136/bmj.327.7418.794 14525881 (Pubitemid 37211176)
2. DS Rigel 2008 Cutaneous ultraviolet exposure and its relationship to the development of skin cancer J Am Acad Dermatol 58 129 132 10.1016/j.jaad.2007.04. 034 (Pubitemid 351506511)
3. B Woerle M Heckmann B Konz 2002 Micrographic surgery of basal cell carcinomas of the head Recent Results Cancer Res 160 219 224 12079216
4. MR Thissen MH Neumann LJ Schouten 1999 A systematic review of treatment modalities for primary basal cell carcinomas Arch Dermatol 135 1177 1183 1:STN:280:DyaK1MvltVCquw%3D%3D 10.1001/archderm.135.10.1177 10522664 (Pubitemid 29493277)
5. SJ Miller M Alam J Andersen D Berg CK Bichakjian G Bowen RT Cheney F Glass RC Grekin JM Grichnik A Kessinger NY Lee S Lessin DD Lydiatt LW Margolis J Michalski KS Nehal P Nghiem AR Oseroff EW Rosenberg AR Shaha RJ Siegle MM Urist National Comprehensive Cancer Network 2007 Basal cell and squamous cell skin cancers J Natl Compr Canc Netw 5 506 529 17509254 (Pubitemid 46815212)
6. HJ Schulze B Cribier L Requena J Reifenberger C Ferrándiz A Garcia Diez V Tebbs S McRae 2005 Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe Br J Dermatol 152 939 947 1:CAS:528:DC%2BD2MXlsFygs7k%3D 10.1111/j.1365-2133.2005.06486.x 15888150 (Pubitemid 40704934)
7. A Huber JD Huber RB Skinner Jr RT Kuwahara R Haque RA Amonette 2004 Topical imiquimod treatment for nodular basal cell carcinomas: an open-label series Dermatol Surg 30 429 430 10.1111/j.1524-4725.2004.30116.x 15008876 (Pubitemid 38524166)
8. T Wetzig M Woitek K Eichhorn JC Simon U Paasch 2010 Surgical excision of basal cell carcinoma with complete margin control: outcome at 5-year follow-up Dermatology 220 363 369 1:STN:280:DC%2BC3cnjsl2gsg%3D%3D 10.1159/000300116 20484877
9. S Shumack J Robinson S Kossard K Macdonald SA Walters M Owens 2002 Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens Arch Dermatol 138 1165 1171 1:CAS:528:DC%2BD38XnvVSksrg%3D 10.1001/archderm.138.9.1165 12224977 (Pubitemid 35025688)
10. MA Blasi D Giammaria E Balestrazzi 2005 Immunotherapy with imiquimod 5% cream for eyelid nodular basal cell carcinoma Am J Ophthalmol 140 1136 1139 1:CAS:528:DC%2BD2MXhtlCrsbzP 10.1016/j.ajo.2005.06.057 16376667 (Pubitemid 41821311)
11. A Kyrgidis K Vahtsevanos TG Tzellos P Xirou K Kitikidou K Antoniades CC Zouboulis S Triaridis 2010 Clinical, histological and demographic predictors for recurrence and second primary tumours of head and neck basal cell carcinoma. A 1062 patient-cohort study from a tertiary cancer referral hospital Eur J Dermatol 20 276 282 20406722
12. TB Fitzpatrick 1975 Soleil et peau J Med Esthet 2 33034
13. Cannon PS, O'Donnell B, Huilgol SC, Selva D (2010) The ophthalmic side-effects of imiquimod therapy in the management of periocular skin lesions. Br J Ophthalmol, Aug 10 [Epub ahead of print]
14. C Quirk K Gebauer M Owens P Stampone 2006 Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeks Australas J Dermatol 47 258 265 10.1111/j.1440-0960.2006.00313.x 17034468 (Pubitemid 44536221)
15. I Leibovitch SC Huilgol D Selva S Richards R Paver 2005 Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up J Am Acad Dermatol 53 452 457 10.1016/j.jaad.2005.04.087 16112352 (Pubitemid 41195967)